Of the 143 patient tumours harbouring SKP1 shallow deletions, ~78% (111/143) occur independent of CCNE1 amplification, while ~22% (32/143) co-occur with CCNE1 gene amplification (Fig. 1b). The gene discussed is SKP1; the disease is neoplasm.